ocal steroid injection in the treatment of idiopathic carpal tunnel syndrome: A randomized double-blind placebo-controlled trial among patients planned for surgical treatment - steroid injection treatment of CTS

Region skåne- Hässleholms sjukvårdsorganisation0 个研究点目标入组 90 人开始时间: 2008年6月16日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•·Primary, idiopathic CTS
•·Age 18-70 years, either gender
•·Symptom duration of at least 3 months and inadequate response to wrist splint
•·Symptoms of classic or probable CTS according to the diagnostic criteria in Katz hand diagram
•·Nerve conduction studies showing median neuropathy at the wrist and no other abnormalities, or in the absence of abnormal nerve conduction study results, 2 surgeons should independently diagnose the patient with CTS.
•·Scheduled for carpal tunnel release (ie, symptom severity indicating need for surgery)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•·Previous steroid injection for CTS in the same wrist
•·Inflammatory joint disease, diabetes mellitus
•·Vibration-induced neuropathy, polyneuropathy
•·Trauma to the affected hand in the previous year
•·Previous CTS surgery in the affected hand
•·Inability to complete questionnaires due to language problem or cognitive disorder
•·Severe medical illness
•·Known abuse of drugs and/or alcohol

发起方

Region skåne- Hässleholms sjukvårdsorganisation